Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Eksterne analyser

Nolato - Better across the board - ABG

Nolato

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier.

Download analyse (PDF)
Q2 outcome
Sales was SEK 2,395m (+2% vs. ABG 2,345m, +2% vs. IR cons 2,351m), down 2% y-o-y, although organic growth was +4% (ABG +2%). EBITA came in at SEK 277m (+5% vs ABG 264m, +7% vs. cons 259m), for an EBITA margin of 11.6% (ABG 11.2%, cons 11.0%). The EBITA beat was mainly driven by Engineered Solutions (+14% vs. cons.), but Medical Solutions was also above (+4%). FCF was decent at SEK 128m (ABG 169m), for an FCF/net income of 60%.

Estimate changes
Nolato does not give formal guidance, but says it is optimistic on H2'25, which we take to believe that the stronger-than-expected Q2 margin should be extrapolated, and note that the Q2 margin is above cons FY'25e estimate. We expect cons EBITA to come up by 4-6%.

Valuation and conference call details
The report was strong across the board, with higher sales and margin, and both segments beating expectations. On our pre-Q2 estimates the share trades at 14x '26e EV/EBITA, and it offers 2-6% lease adj. FCF yields for '25e-'27e. Finally, the company will host a conference call at 08:45 CET, register here.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.